Does Your Policy Cover This Service Line At All
The first and most important question is whether the practice's professional liability policy contemplates medical weight management. Aesthetic practice policies are written around a described scope of services, and that description matters. A policy describing injectables, energy based devices, chemical peels, and skin care may not clearly reach prescribing and managing a medication for a metabolic condition. Some forms list covered procedures or services explicitly, in which case anything not listed may be outside coverage. Others define the scope more broadly but exclude specified categories. The specific items to check are whether the policy covers prescribing and medication management generally, whether it excludes any particular drug class or category of treatment, whether it covers services rendered by each provider type involved including nurse practitioners and physician assistants under the applicable supervision framework, whether telehealth consultations are covered if any part of the service is delivered remotely, and whether the policy's description of operations needs to be amended. The time to resolve this is before launching the service, because the amendment is routine in advance and a coverage dispute afterward is not. A practice adding a new service line should treat notifying the carrier as part of the launch checklist alongside protocols and training.
- Aesthetic policies are written around a described scope that may not reach medication management
- Some forms list covered services, which means unlisted services may be outside coverage
- Check coverage by provider type, and whether telehealth delivery is contemplated
- Notify the carrier and amend the description of operations before launching, not after
Prescribing, Monitoring, and the Standard of Care
The clinical exposures in medical weight management are different from procedural ones, and they map directly onto how a claim would be framed. Allegations in this area center on evaluation and monitoring. Inadequate initial evaluation, including failure to identify contraindications, relevant medical history, or interacting medications. Failure to obtain or interpret appropriate laboratory work. Inadequate informed consent regarding side effects, expected outcomes, and what happens on discontinuation. Insufficient follow up and monitoring during treatment. Failure to recognize and respond to adverse effects. Prescribing outside the scope of the prescriber's license or outside the supervision framework the state requires. And in some cases allegations about marketing claims regarding results. What that means practically is that the defense file for this service line looks like a medical chart rather than a procedure note. Documented initial evaluation with history and medication reconciliation, documented contraindication screening, laboratory results and their interpretation, a written consent specific to the medication and its risks, a documented follow up schedule with evidence it occurred, documented dose decisions and the reasoning, and documented management of reported side effects. The same documentation that supports good care supports the defense, which is the usual relationship. Practices that run this service line with the rigor of a medical practice rather than the rhythm of an aesthetic service are both safer and more insurable.
- Claims focus on evaluation, monitoring, consent, and response to adverse effects
- The defense file resembles a medical chart rather than a procedure note
- Document history, medication reconciliation, contraindication screening, and laboratory interpretation
- Document the follow up schedule, dose decisions and reasoning, and side effect management
Compounded Medication and Sourcing
Sourcing is a distinct exposure and deserves separate attention, because it can create a coverage problem independent of any clinical question. Where a practice uses compounded preparations, the source matters. Compounding pharmacies operate under specific regulatory frameworks, and the distinction between pharmacies compounding for an identified patient and outsourcing facilities producing larger batches carries different requirements. Products obtained outside legitimate regulatory channels create both regulatory and coverage exposure, and many professional liability and products forms contain exclusions tied to products not obtained through authorized distribution or not approved for the use. That exclusion language is the thing to read. A form excluding claims arising from products obtained from other than the manufacturer or an authorized distributor, or from products used other than in accordance with approved labeling, can remove coverage for a service line built on compounded preparations. Practices sometimes hold a policy that excludes the basis of a significant revenue stream. The controls are documentary and boring, which is to say effective. Keep records of sourcing for every lot used, including the pharmacy or facility, its licensure status, and the lot and expiration. Keep records of storage conditions, since temperature excursions matter. Keep patient level records of what lot was administered or dispensed. And verify, at least annually, that the sources you use remain in good standing. Finally, confirm with the carrier specifically how the policy treats compounded preparations. That is a direct question with a direct answer, and it is better asked now.
- Compounding frameworks differ, and sourcing outside legitimate channels creates regulatory and coverage exposure
- Many forms exclude products not obtained through authorized distribution or used outside approved labeling
- Keep lot level sourcing, licensure, storage, and patient administration records
- Ask the carrier directly how the policy treats compounded preparations
The Business Side: Memberships, Refunds, and Marketing
Three commercial features of weight management programs create exposures outside professional liability. Memberships and prepaid programs are first. Patients commonly pay in advance for a multi month program. If the practice closes, the provider leaves, supply is interrupted, or the patient discontinues, there is a refund and unearned revenue question. That is a contractual and consumer protection issue rather than an insured liability, and it is managed through clear written program terms addressing refunds, interruption, and transfer. Some states regulate prepaid service contracts, which is worth checking locally. Second, marketing. Claims about results, before and after imagery, testimonials, and comparative statements all carry regulatory exposure under consumer protection and advertising rules, and in healthcare settings also under professional advertising rules. General liability's personal and advertising injury coverage addresses specific named offenses and is not a general advertising compliance policy, and regulatory proceedings about advertising claims are often outside coverage entirely. A review of marketing materials against applicable rules is a compliance task, not an insurance one. Third, employment and scope. Adding a service line often means adding staff or expanding roles, which raises the same classification and supervision questions that run through the rest of aesthetic practice. Nurse practitioners and physician assistants operate under state specific scope and supervision requirements, and a policy may exclude care rendered outside a provider's scope regardless of how the practice structured it on paper.
- Prepaid program terms should address refunds, interruption, and transfer in writing
- Marketing claims and imagery carry regulatory exposure that insurance generally does not cover
- Advertising regulatory proceedings are often outside coverage entirely
- Scope and supervision requirements are state specific, and policies often exclude out of scope care
Frequently Asked Questions
Related Resources
This article is for general information and is not a substitute for policy language or professional advice.